Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis

BACKGROUND: Being protease inhibitors and owing to their efficacy in SARS-CoV, lopinavir + ritonavir (L/R) combination is being used in the management of COVID-19. In this systematic review and meta-analysis, we have evaluated the comparative safety and efficacy of L/R combination. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Anusuya, Kumar, Subodh, Sarma, Phulen, Kaur, Hardeep, Prajapat, Manisha, Shekhar, Nishant, Bansal, Seema, Avti, Pramod, Hazarika, Mythili, Sharma, Saurabh, Mahendru, Dhruv, Prakash, Ajay, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Systematic Review and Meta-Analysis (Original Article)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722914/
https://www.ncbi.nlm.nih.gov/pubmed/33078733
http://dx.doi.org/10.4103/ijp.IJP_627_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722914/
https://www.ncbi.nlm.nih.gov/pubmed/33078733
http://dx.doi.org/10.4103/ijp.IJP_627_20

Ejemplares similares